ICR Research Department is carrying out a clinical trial lead by Dr. Castillo with patients affected by LHON

Medical content revised by - Last revision 25/06/2021
ICR Research Department is carrying out a clinical trial lead by Dr. Castillo with patients affected by LHON

ICR, at the forefront of research

Dr Castillo, Head of Neuro-Ophthalmology and Teaching Department at Institut Català de Retina, has initiated, alongside the Research Department, a clinical trial developed by Santhera Pharmaceuticals, for which participants affected by Leber Optic Neuropathy (LHON), older than 12 years old and of all genders, are being recruited. The disease must have triggered in the last five years and patients affected must have any of the common mutations (G11778A, G3460A o T14484C).

What kind of disease is Leber’s optic neuropathy?

Leber’s optic neuropathy is a neurodegenerative mitochondrial disease that affects the optic nerve and is characterized by a sudden vision loss in young adults that are genetic carriers of the disease. LHON is considered an Orpha disease, which means is a rare disease.

Its prevalence is really low, and not all mutation carriers developed the symptoms. This means the participant search for the trial is an essential task. Moreover, since it is a mitochondrial disease, only women transmit it genetically to their children, while men carriers do not transmit it.

Other current LHON researches

Dr Castillo, besides leading the research, has also studied the disease in the editorial Leber Hereditary Optic Neuropathy: what therapeutic perspectives do we have? that will be published shortly in the journal Archivos de la Sociedad Española de Oftalmología, and where she analyses and provides her opinion on new therapeutic perspectives for the disease.

The clinical trial, which is currently in participant recruitment phase, is being carried out at a European level, and in Catalonia, Institut Català de Retina is the only centre the develops it. In Spain, only another centre is also performing the trial.

Clinical trial and exclusion criteria

Before participating in the trial, there are several exclusion criteria to highlight, especially having previously undergone a treatment with idebenone. If you wish to read further on the trial, you can check the clinical trial’s website, officially registered at the USA National Health Institute.

Related articles

Leber Hereditary Optic Neuropathy

What is Leber Hereditary Optic Neuropathy? Leber Hereditary Optic Neuropathy (LHON), also known as Leber Optic Atrophy, was named after Doctor Theodore Leber, who described in 1871 a characteristic pattern of sudden vision loss in young men with family history of blindness. It is the most common hereditary optic neuropathy, it is caused by a […]

Dr. Castillo leads a study in Spain to learn more about the natural history of the LHON

GenSight starts a study to better understand the natural history of Leber’s hereditary optic neuropathy (or LHON) – how visual function evolves, what other symptoms can be associated … -, how genetic and environmental factors are related in the development of the disease and the direct or indirect costs for the patient and family. It is […]

Dr. Castillo publishes an editorial on LHON therapeutic perspectives in the journal of the Spanish Society of Ophthalmology

An editorial on LHON therapeutic perspectives (Leber’s Hereditary Optic Neuropathy) from Dr. Lorena Castillo, Head of the Neuro-Ophthalmology Department at ICR, has been published in the December issue of the journal Archivos de la Sociedad Española de Oftalmología. Editorials in medical journals are published by leading specialists in a specific area, and are aimed at […]

Dr Castillo takes part as a speaker in the 10th refresher course on Neuro-ophthalmology

On February 17th and 18th, the 10th refresher course on Neuro-ophthalmology took place in Madrid. It is a biannual event that has been celebrate during the last 18 years with the attendance of between 400 and 500 ophthalmologists. The aim of the course is to offer innovative information on action protocols regarding diagnosis and treatments […]

Do you have any questions?

Contact us or request an appointment with one of our specialists.

Visit us at:

ICR Pau Alcover

C. Pau Alcover 67
08017 Barcelona See map

ICR Ganduxer Headquarters

c/Ganduxer,117
08022 Barcelona See map

ICR Terrassa

77, Del Nord St.
08221 Terrassa See map

ICR Service at Clínica Ntra. Sra. del Remei

c/ de l'Escorial,148
08024 Barcelona See map

Clínica Bonanova Surgical Center

Passeig Bonanova, 22
08022 Barcelona See map

Clinica Bonanova Tests and Treatments

c/ Mandri, 63
08022 Barcelona See map

ICR Pau Alcover

Telephone number (+34) 93 378 23 19

Opening hours:
Monday to Friday from 8 am to 9 pm. Saturday from 8 am to 2 pm.

How to get there More information

ICR Ganduxer Headquarters

Telephone number 93 254 79 20
Emergencies phone number: 93 418 72 27

Opening hours:
Monday to Friday 8 a.m. to 9 p.m.
Saturdays 9 a.m. to 2 p.m.

How to get there More information

ICR Terrassa

Telephone number +34 93 736 34 40

Opening hours:
Monday to Friday from 8:30 a.m. to 2 p.m. and 3 p.m. to 8 p.m.

How to get there More information

ICR Service at Clínica Ntra. Sra. del Remei

Telephone number 902 10 10 50

Opening hours:
Every day from 3 p.m. to 8 p.m. and Friday mornings from 10 a.m. to 2 p.m.

How to get there More information

Clínica Bonanova Surgical Center

Telephone number 934 34 09 25

Opening hours:
Monday to Friday from 7:30 a.m. to 8:30 p.m.

How to get there More information

Clinica Bonanova Tests and Treatments

How to get there More information